Short-term effects of the vagal stimulation in patients with coronary disease.

Not Applicable

Completed

• Conditions: Coronary Heart disease; Cardiovascular - Coronary heart disease

• Registration Number: ACTRN12616000380493
• Lead Sponsor: niversity of Seville

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2016-03-23
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Coronary heart disease

Exclusion Criteria

Previous surgery for coronary heart disease in the past 3 years and concomitant disease were excluded

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
systolic blood pressure using sphygmomanometer[ 6 weeks after commencement of intervention period.]; diastolic blood pressure using sphygmomanometer[ 6 weeks after commencement of intervention period.];maximal oxygen uptake (VO2 max)using the Cooper test[6 weeks after commencement of intervention period]

Secondary Outcome Measures

Name	Time	Method
catecholamines using blood sample[ 6 weeks after commencement of intervention period];cortisol using blood sample[ 6 weeks after commencement of intervention period.];hdl-cholesterol using blood sample[ 6 weeks after commencement of intervention period.];cholesterol using blood sample[ 6 weeks after commencement of intervention period.]